A group of oncologists has formed a non-profit drug company to fight the U.S. drug shortage, which includes at least 180 medications designed to treat cancer, according to a New York Times report.
The group aims to import some of the cancer medicines and eventually manufacture the drugs on its own.
The shortage has forced prices for some cancer drugs to increase twentyfold and has delayed some clinical trials for experimental cures. In addition, at least one cancer patient was turned away from a center due to a lack of medication, according to the report.
The government is considering solutions to the shortage, including creation of a stockpile of cancer medication.
4 Strategies to Manage the Drug Shortage From Dr. John Dombrowski
Pharmacists, Physicians Try to Cope With Drug Shortages
The group aims to import some of the cancer medicines and eventually manufacture the drugs on its own.
The shortage has forced prices for some cancer drugs to increase twentyfold and has delayed some clinical trials for experimental cures. In addition, at least one cancer patient was turned away from a center due to a lack of medication, according to the report.
The government is considering solutions to the shortage, including creation of a stockpile of cancer medication.
Related Articles on Drug Shortages:
Hospital Drug Shortage Survey Mirrors Results of American Society of Anesthesiologists Survey4 Strategies to Manage the Drug Shortage From Dr. John Dombrowski
Pharmacists, Physicians Try to Cope With Drug Shortages